Impact of hypercalcemia and parathyroid hormone level on the sensitivity of preoperative sestamibi scanning for primary hyperparathyroidism

American Surgeon

Volumn 69, Issue 5, 2003, Pages 393-398

  Parikshak, Manesh ^a   Castillo, Eduardo D ^a   Conrad, Mark F ^a   Talpos, Gary B ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE; RADIOPHARMACEUTICAL AGENT;

ADENOMA; AGED; ARTICLE; BLOOD; FEMALE; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; PARATHYROID TUMOR; PARATHYROIDECTOMY; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADENOMA; AGED; CALCIUM; FEMALE; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; PARATHYROID HORMONE; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0038687096     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Mandl F. Therapeutishcer Versuch bei Osteitis fibrosa generalisata mittels Exstirpation eines Epithelkörperchen tumors. Wien Klin Wochenschr 1925;50:1343-1344
2. Uden P, Chan A, Duh QY, et al. Primary hyperparathyroidism in younger and older patients: symptoms and outcome of surgery. World J Surg 1192;16:791-798
3. Irvin GL, Carneiro DM. Management changes in primary hyperparathyroidism. JAMA 2000;284:934-936
4. NIH Conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus Development Conference statement. Ann Intern Med 1991;114:593-597
5. Silverberg SJ, Shane E, Jacobs TP, et al. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 1999;341:1249-1255 (Pubitemid 29489739)
6. Strewler GJ. Indications for surgery in patients with minimally symptomatic primary hyperparathyroidism. Surg Clin North Am 1995;75:439-447
7. Wermers RA, Khosla S, Atkinson EJ, et al. Survival after the diagnosis of hyperparathyroidism: A population based study. Am J Med 1998;104:115-122 (Pubitemid 28117404)
8. Richards ML, Thompson NW. Diabetes mellitus with hyperparathyroidism: Another indication for parathyroidectomy? Surgery 1999;126:1160-1166
9. Nilsson IL, Aberg J, Rastad J, Lind L. Endothelial vasodilatory dysfunction in primary hyperparathyroidism is revered after parathyroidectomy. Surgery 1999;126:1049-1055
10. Burney RE, Jones KR, Christy B, Thompson NW. Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels. Surgery 1999;125:608-614 (Pubitemid 29265002)
11. Talpos GB, Bone HG, Kleerekoper M, et al. Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: Patient description and effects on the SF-36 health survey. Surgery 2000;128:1013-1021
12. Clark OH. American Association of Endocrine Surgeons Presidential Address: Asymptomatic primary hyperparathyroidism: Is parathyroidectomy indicated? Surgery 1994;116:947-53.
13. Kaplan E, Yashiro T, Salti G. Primary hyperparathyroidism in the 1990s: Choice of surgical procedures for the disease. Ann Surg 1992;215:300-316
14. Tibblen S, Bondenson AG, Ljungberg O. Unilateral parathyroidectomy in hyperparathyroidism due to single adenoma. Ann Surg 1982;195:245-251 (Pubitemid 12185009)
15. Chen H, Sokoll LJ, Udelsman R. Outpatient minimally invasive parathyroidectomy: A combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay. Surgery 1999;126:1016-1022
16. Coakley AJ, Kettle AG, Wells CP, et al. 99m-Tc sestamibi: A new agent for parathyroid imaging. Nucl Med Commun 1989;10:791-794
17. Johnston LB, Carroll MJ, Britton KE, et al. The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging. J Clin Endocrinol Metab 1996;81;346-352
18. Pattou F, Huglo D, Proye C. Radionuclide scanning in parathyroid diseases. Br J Surg 1998;85;1605-1616
19. Thompson GB, Mullan RC, Grant CS, et al. Parathyroid imaging with technetium-99m-sestamibi: An institutional experience. Surgery 1994;116:966-973
20. Carty SE, Worsey J, Virji MA, et al. Concise parathyroidectomy: The impact of preoperative SPECT 99mTc sestamibi scanning and intraoperative quick parathormone assay. Surgery 1997;122:1107-1116
21. Chen CC, Holder LE, Scovill WA, et al. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT. J Nucl Med 1997;38:834-839
22. McHenry CR, Lee K, Saadey J, et al. Parathyroid localization with technetium-99m-sestamibi: A prospective evaluation. J Am Coll Surg 1996;183:25-30. (Pubitemid 26234890)
23. Moka D, Voth E, Dietlein M, et al. Technitium 99m-MIBI-SPECT: A highly sensitive diagnostic tool for localization of parathyroid adenomas. Surgery 2000;128:29-35. (Pubitemid 30456892)
24. Denham DW, Norman J. Cost effectiveness of preoperative sestamibi scan for primary hyperparathyroidism is dependent solely on the surgeon's choice of operative procedure. J Am Coll Surg 1998:186;293-300. (Pubitemid 28124434)
25. Chan TYK, Serpell JW, Chan O, et al. Misinterpretation of the upper parathyroid adenoma on thallium-201/technetium-99m subtraction scintigraphy. Br J Radiol 1991;64:1-4.
26. Duh QY, Uden P, Clark OH. Unilateral neck exploration for primary hyperparathyroidism: Analysis of a controversy using a mathematical model. World J Surg 1992:16:654-659